RJA
LOGC

Raymond James & Associates’s LogicBio Therapeutics, Inc. Common Stock LOGC Stock Holding History

Raymond James & Associates’s Portfolio LOGC Stock Details LOGC Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-10,474
Closed -$76K – 4031
2021
Q1 		$76K Buy
+10,474
New +$76K ﹤0.01% 3743